Jacob Laubach, Md

This study is testing whether adding the investigational drug isatuximab to a standard three-drug chemotherapy regimen is safe and more effective for people newly diagnosed with multiple myeloma. The goal is to better control the cancer before patients undergo a stem cell transpl…